- TESCAN is a manufacturer of electron microscopes and other scientific instruments
- The company’s customer base comprises organisations across the public and private sectors
- Carlyle plans to invest in new products, and further internationalise the business
Carlyle took a majority stake in TESCAN ORSAY, a manufacturer of electron microscopes and other scientific instruments.
Headquartered in Brno, Czech Republic, TESCAN develops and supplies scanning electron microscopes, focused ion beam scanning electron microscopes, micro-CT scanners, and 4D scanning transmission electron microscopes. The company’s customer base comprises organisations across the public and private sectors, including blue-chip corporations and academic institutions.
TESCAN ORSAY formed in 2013 following the combination of TESCAN and Fuveau, France-based ORSAY PHYSICS. The group operates from 14 sites across the world, including two production facilities in Brno.
The Carlyle Europe Technology Partners (CETP) platform plans to invest in new products and and further internationalise TESCAN.
“TESCAN is a unique business and the last independent player in its sector,” said Vladimir Lasocki, managing director and co-Head of the CETP investment advisory. “In this attractive primary opportunity, we recognize the potential to build on our domain knowledge of the analytical instruments market by working with the company to unlock the next level of growth as its large and varied end markets continue to expand and evolve.”
Carlyle, headquartered in Washington D.C., is a multinational private equity, alternative asset management and financial services corporation with $369 billion of assets under management as of September 30, 2022.